1/10/2008 8:37:23 AM
MADISON, Miss.--(BUSINESS WIRE)--Cypress Pharmaceutical, Inc., today announced that it has entered into a multiple generic product development and marketing agreement with Standard Chem. & Pharm. Co., Ltd., (TAIWAN:1720), a global pharmaceutical company. The agreement encompasses the development and US commercialization of an estimated 3.4 billion dollars in product market capitalization.
comments powered by